1504 ET -- Roche Holding and Pfizer are among the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. Roche agreed to buy Telavant Holdings from Roivant Sciences and Pfizer, a deal that includes $7.1 billion upfront and a near-term milestone payment of $150 million. Telavant is developing a bowel-disease treatment. On Friday, Pfizer said the Food and Drug Administration approved Penbraya, a vaccine for meningococcal disease. Dow Jones & Co. owns Factiva. (josh.beckerman@wsj.com)

(END) Dow Jones Newswires

October 23, 2023 15:26 ET (19:26 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Roivant Sciences (NASDAQ:ROIV)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Roivant Sciences.
Roivant Sciences (NASDAQ:ROIV)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Roivant Sciences.